

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | locomotory exploration behavior (GO:0035641) | 4.77305544 |
| 2 | synaptic vesicle maturation (GO:0016188) | 4.53107568 |
| 3 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 4.43595643 |
| 4 | positive regulation of synapse maturation (GO:0090129) | 4.38392111 |
| 5 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.28759416 |
| 6 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 4.21296603 |
| 7 | NADH metabolic process (GO:0006734) | 4.11659010 |
| 8 | neuronal action potential propagation (GO:0019227) | 3.93499673 |
| 9 | vocalization behavior (GO:0071625) | 3.92878950 |
| 10 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 3.75632180 |
| 11 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.72943719 |
| 12 | glutamate secretion (GO:0014047) | 3.70998648 |
| 13 | sodium ion export (GO:0071436) | 3.67531210 |
| 14 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.64251421 |
| 15 | cellular potassium ion homeostasis (GO:0030007) | 3.63222431 |
| 16 | regulation of synaptic vesicle exocytosis (GO:2000300) | 3.62568078 |
| 17 | gamma-aminobutyric acid transport (GO:0015812) | 3.61429629 |
| 18 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.61407122 |
| 19 | amino acid import (GO:0043090) | 3.60851549 |
| 20 | layer formation in cerebral cortex (GO:0021819) | 3.58068288 |
| 21 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 3.56952163 |
| 22 | creatine metabolic process (GO:0006600) | 3.56920767 |
| 23 | oxaloacetate metabolic process (GO:0006107) | 3.56313907 |
| 24 | synaptic vesicle exocytosis (GO:0016079) | 3.52313963 |
| 25 | regulation of synapse structural plasticity (GO:0051823) | 3.46570303 |
| 26 | regulation of synapse maturation (GO:0090128) | 3.45670148 |
| 27 | neurotransmitter secretion (GO:0007269) | 3.45080978 |
| 28 | potassium ion import (GO:0010107) | 3.38358351 |
| 29 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.37652662 |
| 30 | dendritic spine morphogenesis (GO:0060997) | 3.37147549 |
| 31 | cell communication by electrical coupling (GO:0010644) | 3.35252612 |
| 32 | activation of protein kinase A activity (GO:0034199) | 3.35240932 |
| 33 | regulation of female receptivity (GO:0045924) | 3.29783156 |
| 34 | negative regulation of dendrite morphogenesis (GO:0050774) | 3.28834635 |
| 35 | glycine transport (GO:0015816) | 3.28576665 |
| 36 | regulation of synaptic vesicle transport (GO:1902803) | 3.28174213 |
| 37 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.28038811 |
| 38 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.27091601 |
| 39 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 3.26815950 |
| 40 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.25602132 |
| 41 | exploration behavior (GO:0035640) | 3.25486894 |
| 42 | myelin maintenance (GO:0043217) | 3.24417864 |
| 43 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.23480617 |
| 44 | positive regulation of Rap GTPase activity (GO:0032854) | 3.21130526 |
| 45 | cell communication involved in cardiac conduction (GO:0086065) | 3.12516642 |
| 46 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 3.08707273 |
| 47 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.06614180 |
| 48 | neuromuscular process controlling balance (GO:0050885) | 2.98883559 |
| 49 | long-term memory (GO:0007616) | 2.97285263 |
| 50 | neurotransmitter-gated ion channel clustering (GO:0072578) | 2.95294413 |
| 51 | neuromuscular process controlling posture (GO:0050884) | 2.94438756 |
| 52 | proline transport (GO:0015824) | 2.94319303 |
| 53 | regulation of membrane repolarization (GO:0060306) | 2.91710465 |
| 54 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.90731271 |
| 55 | cell volume homeostasis (GO:0006884) | 2.89018143 |
| 56 | response to parathyroid hormone (GO:0071107) | 2.88792705 |
| 57 | axon ensheathment in central nervous system (GO:0032291) | 2.86919699 |
| 58 | central nervous system myelination (GO:0022010) | 2.86919699 |
| 59 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 2.86502853 |
| 60 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.85216432 |
| 61 | vitamin transmembrane transport (GO:0035461) | 2.85061382 |
| 62 | protein localization to synapse (GO:0035418) | 2.84904725 |
| 63 | neurotransmitter transport (GO:0006836) | 2.84203999 |
| 64 | chemosensory behavior (GO:0007635) | 2.82822622 |
| 65 | regulation of mitotic spindle organization (GO:0060236) | 2.82321228 |
| 66 | synaptic transmission, glutamatergic (GO:0035249) | 2.80972167 |
| 67 | cardiac conduction (GO:0061337) | 2.79790412 |
| 68 | prepulse inhibition (GO:0060134) | 2.78989057 |
| 69 | glutamate receptor signaling pathway (GO:0007215) | 2.78550378 |
| 70 | positive regulation of membrane potential (GO:0045838) | 2.77281455 |
| 71 | mating behavior (GO:0007617) | 2.76423334 |
| 72 | cellular sodium ion homeostasis (GO:0006883) | 2.75968682 |
| 73 | potassium ion homeostasis (GO:0055075) | 2.75677981 |
| 74 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 2.74923798 |
| 75 | sodium ion homeostasis (GO:0055078) | 2.73210635 |
| 76 | L-amino acid import (GO:0043092) | 2.72733607 |
| 77 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 2.72399775 |
| 78 | cerebellar Purkinje cell layer development (GO:0021680) | 2.70202999 |
| 79 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 2.69821507 |
| 80 | neuron-neuron synaptic transmission (GO:0007270) | 2.69633166 |
| 81 | regulation of neurotransmitter levels (GO:0001505) | 2.69362549 |
| 82 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 2.69308612 |
| 83 | auditory behavior (GO:0031223) | 2.68870378 |
| 84 | transmission of nerve impulse (GO:0019226) | 2.68448364 |
| 85 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 2.67462456 |
| 86 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 2.66659195 |
| 87 | female mating behavior (GO:0060180) | 2.66513880 |
| 88 | membrane repolarization (GO:0086009) | 2.66356263 |
| 89 | regulation of early endosome to late endosome transport (GO:2000641) | 2.66193727 |
| 90 | positive regulation of cellular amine metabolic process (GO:0033240) | 2.64631765 |
| 91 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 2.64559007 |
| 92 | signal complex assembly (GO:0007172) | 2.64344109 |
| 93 | positive regulation of potassium ion transport (GO:0043268) | 2.64213966 |
| 94 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.64101729 |
| 95 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.63744582 |
| 96 | triglyceride catabolic process (GO:0019433) | 2.63571613 |
| 97 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 2.62824214 |
| 98 | neuron cell-cell adhesion (GO:0007158) | 2.61389706 |
| 99 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.61309536 |
| 100 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 2.61305579 |
| 101 | positive regulation of sodium ion transport (GO:0010765) | 2.59687053 |
| 102 | neuronal ion channel clustering (GO:0045161) | 2.59580878 |
| 103 | long-term synaptic potentiation (GO:0060291) | 2.58210256 |
| 104 | regulation of oxidative phosphorylation (GO:0002082) | 2.58158288 |
| 105 | regulation of clathrin-mediated endocytosis (GO:2000369) | 2.58139886 |
| 106 | regulation of ARF protein signal transduction (GO:0032012) | 2.57989448 |
| 107 | aspartate family amino acid catabolic process (GO:0009068) | 2.57372489 |
| 108 | phosphate ion transmembrane transport (GO:0035435) | 2.57058375 |
| 109 | positive regulation of protein dephosphorylation (GO:0035307) | 2.57047728 |
| 110 | dopamine receptor signaling pathway (GO:0007212) | 2.56738163 |
| 111 | acylglycerol catabolic process (GO:0046464) | 2.55767731 |
| 112 | neutral lipid catabolic process (GO:0046461) | 2.55767731 |
| 113 | dendrite morphogenesis (GO:0048813) | 2.55174371 |
| 114 | regulation of cell communication by electrical coupling (GO:0010649) | 2.55126519 |
| 115 | lysine catabolic process (GO:0006554) | 2.54927914 |
| 116 | lysine metabolic process (GO:0006553) | 2.54927914 |
| 117 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 2.54767907 |
| 118 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.54173325 |
| 119 | membrane repolarization during cardiac muscle cell action potential (GO:0086013) | 2.52867505 |
| 120 | regulation of protein dephosphorylation (GO:0035304) | 2.52408682 |
| 121 | regulation of histone H3-K27 methylation (GO:0061085) | 2.52205912 |
| 122 | regulation of dendritic spine development (GO:0060998) | 2.51343416 |
| 123 | detection of calcium ion (GO:0005513) | 2.51303034 |
| 124 | behavioral response to cocaine (GO:0048148) | 2.51145470 |
| 125 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 2.51073879 |
| 126 | membrane depolarization during action potential (GO:0086010) | 2.50601678 |
| 127 | regulation of Rap GTPase activity (GO:0032317) | 2.49783226 |
| 128 | regulation of vesicle fusion (GO:0031338) | 2.49143084 |
| 129 | dicarboxylic acid biosynthetic process (GO:0043650) | 2.48907690 |
| 130 | regulation of heart rate by cardiac conduction (GO:0086091) | 2.47218604 |
| 131 | ventricular cardiac muscle cell action potential (GO:0086005) | 2.46667270 |
| 132 | neurotransmitter uptake (GO:0001504) | 2.45607808 |
| 133 | regulation of postsynaptic membrane potential (GO:0060078) | 2.45585579 |
| 134 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 2.45558259 |
| 135 | regulation of calcium ion transmembrane transport (GO:1903169) | 2.45558259 |
| 136 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 2.45332625 |
| 137 | regulation of synaptic plasticity (GO:0048167) | 2.44511854 |
| 138 | carnitine shuttle (GO:0006853) | 2.42490900 |
| 139 | regulation of ion transmembrane transporter activity (GO:0032412) | 2.41933499 |
| 140 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 2.40647998 |
| 141 | alanine transport (GO:0032328) | 2.40392894 |
| 142 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.40345990 |
| 143 | plasma membrane repair (GO:0001778) | 2.40316890 |
| 144 | positive regulation of dendritic spine development (GO:0060999) | 2.40199910 |
| 145 | glutamate metabolic process (GO:0006536) | 2.39821704 |
| 146 | cerebellar granule cell differentiation (GO:0021707) | 2.39344844 |
| 147 | ethanol oxidation (GO:0006069) | 2.37557518 |
| 148 | regulation of neurotransmitter secretion (GO:0046928) | 2.35079965 |
| 149 | water transport (GO:0006833) | 2.34443769 |
| 150 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.34286603 |
| 151 | L-phenylalanine metabolic process (GO:0006558) | 2.34286603 |
| 152 | synaptic vesicle endocytosis (GO:0048488) | 2.34134245 |
| 153 | adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191) | 2.33032542 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.48340596 |
| 2 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.69588742 |
| 3 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.56773432 |
| 4 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.54367413 |
| 5 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.49653868 |
| 6 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.49653868 |
| 7 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.33821826 |
| 8 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.33624300 |
| 9 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.30803866 |
| 10 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.27992555 |
| 11 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.23208166 |
| 12 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.21798790 |
| 13 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.16314303 |
| 14 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.13236140 |
| 15 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.03681309 |
| 16 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.03076181 |
| 17 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.02588326 |
| 18 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.01196187 |
| 19 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.98267622 |
| 20 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.94945633 |
| 21 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.93934299 |
| 22 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.89039936 |
| 23 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.88854142 |
| 24 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.85898593 |
| 25 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.84661135 |
| 26 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.82237247 |
| 27 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.79913501 |
| 28 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.79845702 |
| 29 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.79708443 |
| 30 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.78402273 |
| 31 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.77103532 |
| 32 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.72502613 |
| 33 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.72286044 |
| 34 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.72161726 |
| 35 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.71290158 |
| 36 | P68_20966046_ChIP-Seq_HELA_Human | 1.65969357 |
| 37 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.64580119 |
| 38 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.64551392 |
| 39 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.64504585 |
| 40 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.61204220 |
| 41 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.60861097 |
| 42 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.59560036 |
| 43 | MYC_22102868_ChIP-Seq_BL_Human | 1.58663715 |
| 44 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.55657306 |
| 45 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.51036234 |
| 46 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.50164328 |
| 47 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.49559026 |
| 48 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.49196358 |
| 49 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 1.47490347 |
| 50 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.46518528 |
| 51 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.43296991 |
| 52 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.42296427 |
| 53 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.41433588 |
| 54 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.40222506 |
| 55 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.36554992 |
| 56 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.36548784 |
| 57 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.33336202 |
| 58 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.33138959 |
| 59 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.32324979 |
| 60 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.30943002 |
| 61 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.30185751 |
| 62 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.28042023 |
| 63 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.27993514 |
| 64 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.27955266 |
| 65 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.26867117 |
| 66 | FLI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.26269844 |
| 67 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.25135589 |
| 68 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.24915103 |
| 69 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.23696990 |
| 70 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.22811266 |
| 71 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.22809305 |
| 72 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.22152327 |
| 73 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.22131326 |
| 74 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.21192096 |
| 75 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.20784901 |
| 76 | KDM2B_26808549_Chip-Seq_K562_Human | 1.20768626 |
| 77 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.18700436 |
| 78 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.17801665 |
| 79 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.17332766 |
| 80 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.16891786 |
| 81 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.16314137 |
| 82 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.16137361 |
| 83 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.15923108 |
| 84 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.14900971 |
| 85 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.13905604 |
| 86 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.13581377 |
| 87 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.13482934 |
| 88 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.12794946 |
| 89 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.12484529 |
| 90 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.12484529 |
| 91 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.11865605 |
| 92 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.11826065 |
| 93 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.11557288 |
| 94 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.11400416 |
| 95 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.11289447 |
| 96 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.11087653 |
| 97 | OCT4_19829295_ChIP-Seq_ESCs_Human | 1.10816327 |
| 98 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.10448926 |
| 99 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.10083009 |
| 100 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.09852142 |
| 101 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.08322649 |
| 102 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.07664411 |
| 103 | AR_19668381_ChIP-Seq_PC3_Human | 1.07417151 |
| 104 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.06494661 |
| 105 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.06349931 |
| 106 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.05779169 |
| 107 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.05661909 |
| 108 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.05325722 |
| 109 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.04970430 |
| 110 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.04315682 |
| 111 | GATA1_19941826_ChIP-Seq_K562_Human | 1.03937286 |
| 112 | SA1_27219007_Chip-Seq_Bcells_Human | 1.03355385 |
| 113 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.03286669 |
| 114 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.02588986 |
| 115 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.02361192 |
| 116 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.01489153 |
| 117 | ETS1_21867929_ChIP-Seq_TH2_Mouse | 1.00596197 |
| 118 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 1.00221926 |
| 119 | RXR_22108803_ChIP-Seq_LS180_Human | 1.00125988 |
| 120 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.99954700 |
| 121 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 0.98986291 |
| 122 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.98955397 |
| 123 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.98898014 |
| 124 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.98829649 |
| 125 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.98166802 |
| 126 | STAT3_23295773_ChIP-Seq_U87_Human | 0.97858925 |
| 127 | SETDB1_19884255_ChIP-Seq_MESCs_Mouse | 0.97779067 |
| 128 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.97649640 |
| 129 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.97641827 |
| 130 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.97565611 |
| 131 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.95535706 |
| 132 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.95493439 |
| 133 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.95202351 |
| 134 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 0.94704856 |
| 135 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.94590624 |
| 136 | AR_25329375_ChIP-Seq_VCAP_Human | 0.94136452 |
| 137 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.93931999 |
| 138 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.93676671 |
| 139 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.93477446 |
| 140 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.93083992 |
| 141 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.92899857 |
| 142 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.90485200 |
| 143 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.89224075 |
| 144 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.89154068 |
| 145 | TP53_16413492_ChIP-PET_HCT116_Human | 0.88345685 |
| 146 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.88271034 |
| 147 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.87616274 |
| 148 | KLF4_19829295_ChIP-Seq_ESCs_Human | 0.87086382 |
| 149 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 0.84562493 |
| 150 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.84223987 |
| 151 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.84103206 |
| 152 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 0.83990047 |
| 153 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.83938438 |
| 154 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.83413489 |
| 155 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.83091372 |
| 156 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.80983622 |
| 157 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.80959515 |
| 158 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.80922966 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 5.21762586 |
| 2 | MP0003635_abnormal_synaptic_transmissio | 3.22418060 |
| 3 | MP0005670_abnormal_white_adipose | 3.17209404 |
| 4 | MP0003880_abnormal_central_pattern | 3.05644702 |
| 5 | MP0004270_analgesia | 3.00272054 |
| 6 | MP0002822_catalepsy | 2.98578144 |
| 7 | MP0009745_abnormal_behavioral_response | 2.58091400 |
| 8 | MP0004043_abnormal_pH_regulation | 2.57221310 |
| 9 | MP0000751_myopathy | 2.43765690 |
| 10 | MP0002063_abnormal_learning/memory/cond | 2.40801382 |
| 11 | MP0002064_seizures | 2.39916955 |
| 12 | MP0009046_muscle_twitch | 2.37383160 |
| 13 | MP0002837_dystrophic_cardiac_calcinosis | 2.37319360 |
| 14 | MP0001486_abnormal_startle_reflex | 2.17487501 |
| 15 | MP0004215_abnormal_myocardial_fiber | 2.11235693 |
| 16 | MP0003123_paternal_imprinting | 2.08996906 |
| 17 | MP0000678_abnormal_parathyroid_gland | 2.05949055 |
| 18 | MP0009780_abnormal_chondrocyte_physiolo | 2.04350972 |
| 19 | MP0005423_abnormal_somatic_nervous | 2.04231476 |
| 20 | MP0002272_abnormal_nervous_system | 2.03849487 |
| 21 | MP0003646_muscle_fatigue | 2.01975996 |
| 22 | MP0004145_abnormal_muscle_electrophysio | 1.99100646 |
| 23 | MP0002909_abnormal_adrenal_gland | 1.93934700 |
| 24 | MP0002734_abnormal_mechanical_nocicepti | 1.89586721 |
| 25 | MP0002572_abnormal_emotion/affect_behav | 1.88742016 |
| 26 | MP0003329_amyloid_beta_deposits | 1.87183314 |
| 27 | MP0004885_abnormal_endolymph | 1.87029148 |
| 28 | MP0001502_abnormal_circadian_rhythm | 1.81870160 |
| 29 | MP0005360_urolithiasis | 1.80238443 |
| 30 | MP0005409_darkened_coat_color | 1.76108782 |
| 31 | MP0001440_abnormal_grooming_behavior | 1.75640964 |
| 32 | MP0001501_abnormal_sleep_pattern | 1.73442522 |
| 33 | MP0008569_lethality_at_weaning | 1.70693010 |
| 34 | MP0004084_abnormal_cardiac_muscle | 1.68750548 |
| 35 | MP0004036_abnormal_muscle_relaxation | 1.66940694 |
| 36 | MP0004130_abnormal_muscle_cell | 1.65920937 |
| 37 | MP0001968_abnormal_touch/_nociception | 1.65516421 |
| 38 | MP0005085_abnormal_gallbladder_physiolo | 1.55892634 |
| 39 | MP0004484_altered_response_of | 1.49561225 |
| 40 | MP0002139_abnormal_hepatobiliary_system | 1.46898293 |
| 41 | MP0004019_abnormal_vitamin_homeostasis | 1.43104031 |
| 42 | MP0003690_abnormal_glial_cell | 1.42843099 |
| 43 | MP0008961_abnormal_basal_metabolism | 1.42234212 |
| 44 | MP0002067_abnormal_sensory_capabilities | 1.40870520 |
| 45 | MP0000747_muscle_weakness | 1.39203895 |
| 46 | MP0003137_abnormal_impulse_conducting | 1.39090895 |
| 47 | MP0005330_cardiomyopathy | 1.38082262 |
| 48 | MP0005386_behavior/neurological_phenoty | 1.36545416 |
| 49 | MP0004924_abnormal_behavior | 1.36545416 |
| 50 | MP0003879_abnormal_hair_cell | 1.35517141 |
| 51 | MP0002796_impaired_skin_barrier | 1.33294516 |
| 52 | MP0009672_abnormal_birth_weight | 1.31761502 |
| 53 | MP0004085_abnormal_heartbeat | 1.30894901 |
| 54 | MP0001970_abnormal_pain_threshold | 1.28873910 |
| 55 | MP0003195_calcinosis | 1.27765318 |
| 56 | MP0005535_abnormal_body_temperature | 1.27584789 |
| 57 | MP0002733_abnormal_thermal_nociception | 1.25983420 |
| 58 | MP0005620_abnormal_muscle_contractility | 1.25547512 |
| 59 | * MP0006036_abnormal_mitochondrial_physio | 1.23861525 |
| 60 | MP0003633_abnormal_nervous_system | 1.18682255 |
| 61 | MP0002066_abnormal_motor_capabilities/c | 1.16550237 |
| 62 | MP0001346_abnormal_lacrimal_gland | 1.16463618 |
| 63 | MP0005332_abnormal_amino_acid | 1.15400134 |
| 64 | MP0000013_abnormal_adipose_tissue | 1.15370224 |
| 65 | MP0002249_abnormal_larynx_morphology | 1.14901220 |
| 66 | MP0004087_abnormal_muscle_fiber | 1.14860772 |
| 67 | MP0008875_abnormal_xenobiotic_pharmacok | 1.14419935 |
| 68 | MP0002557_abnormal_social/conspecific_i | 1.13446637 |
| 69 | MP0005167_abnormal_blood-brain_barrier | 1.13399836 |
| 70 | MP0004858_abnormal_nervous_system | 1.12733206 |
| 71 | MP0003172_abnormal_lysosome_physiology | 1.12661619 |
| 72 | MP0002972_abnormal_cardiac_muscle | 1.10139246 |
| 73 | MP0002184_abnormal_innervation | 1.09420816 |
| 74 | MP0005646_abnormal_pituitary_gland | 1.09283850 |
| 75 | MP0000920_abnormal_myelination | 1.04808561 |
| 76 | MP0001485_abnormal_pinna_reflex | 1.03749338 |
| 77 | MP0003868_abnormal_feces_composition | 1.03048003 |
| 78 | MP0000955_abnormal_spinal_cord | 1.02660818 |
| 79 | MP0002736_abnormal_nociception_after | 1.02074495 |
| 80 | MP0004811_abnormal_neuron_physiology | 1.01949763 |
| 81 | MP0009115_abnormal_fat_cell | 1.00809905 |
| 82 | MP0000003_abnormal_adipose_tissue | 1.00287832 |
| 83 | MP0000566_synostosis | 0.99992854 |
| 84 | MP0002735_abnormal_chemical_nociception | 0.99943013 |
| 85 | MP0006138_congestive_heart_failure | 0.99320499 |
| 86 | MP0008775_abnormal_heart_ventricle | 0.99242701 |
| 87 | MP0005365_abnormal_bile_salt | 0.98479462 |
| 88 | MP0000778_abnormal_nervous_system | 0.97791751 |
| 89 | MP0002970_abnormal_white_adipose | 0.97635065 |
| 90 | MP0000749_muscle_degeneration | 0.96893309 |
| 91 | MP0005623_abnormal_meninges_morphology | 0.96016528 |
| 92 | MP0005666_abnormal_adipose_tissue | 0.95940708 |
| 93 | MP0010630_abnormal_cardiac_muscle | 0.94599312 |
| 94 | MP0002106_abnormal_muscle_physiology | 0.94350096 |
| 95 | MP0004185_abnormal_adipocyte_glucose | 0.92635541 |
| 96 | MP0005448_abnormal_energy_balance | 0.92580119 |
| 97 | MP0002882_abnormal_neuron_morphology | 0.92086079 |
| 98 | MP0003631_nervous_system_phenotype | 0.90878807 |
| 99 | MP0002876_abnormal_thyroid_physiology | 0.89306338 |
| 100 | MP0010329_abnormal_lipoprotein_level | 0.89195689 |
| 101 | MP0010234_abnormal_vibrissa_follicle | 0.88853382 |
| 102 | MP0004233_abnormal_muscle_weight | 0.88653146 |
| 103 | MP0004142_abnormal_muscle_tone | 0.88261719 |
| 104 | MP0001765_abnormal_ion_homeostasis | 0.87622389 |
| 105 | MP0008872_abnormal_physiological_respon | 0.87446820 |
| 106 | MP0001666_abnormal_nutrient_absorption | 0.87131890 |
| 107 | MP0003283_abnormal_digestive_organ | 0.86997641 |
| 108 | MP0008874_decreased_physiological_sensi | 0.86349927 |
| 109 | MP0002118_abnormal_lipid_homeostasis | 0.85754467 |
| 110 | MP0003075_altered_response_to | 0.85601255 |
| 111 | MP0002396_abnormal_hematopoietic_system | 0.84859107 |
| 112 | MP0005187_abnormal_penis_morphology | 0.83848488 |
| 113 | MP0005452_abnormal_adipose_tissue | 0.83654528 |
| 114 | MP0002069_abnormal_eating/drinking_beha | 0.83555441 |
| 115 | MP0005369_muscle_phenotype | 0.82605531 |
| 116 | MP0002078_abnormal_glucose_homeostasis | 0.81469115 |
| 117 | MP0003787_abnormal_imprinting | 0.81418351 |
| 118 | MP0001984_abnormal_olfaction | 0.81162012 |
| 119 | MP0002269_muscular_atrophy | 0.80790746 |
| 120 | MP0001730_embryonic_growth_arrest | 0.80691510 |
| 121 | MP0003252_abnormal_bile_duct | 0.79990185 |
| 122 | MP0000230_abnormal_systemic_arterial | 0.79399979 |
| 123 | MP0001177_atelectasis | 0.78857107 |
| 124 | MP0000604_amyloidosis | 0.78809296 |
| 125 | MP0002971_abnormal_brown_adipose | 0.78463189 |
| 126 | MP0005375_adipose_tissue_phenotype | 0.77974516 |
| 127 | MP0002229_neurodegeneration | 0.77605809 |
| 128 | MP0004264_abnormal_extraembryonic_tissu | 0.77522758 |
| 129 | MP0005166_decreased_susceptibility_to | 0.75853785 |
| 130 | MP0005385_cardiovascular_system_phenoty | 0.75171017 |
| 131 | MP0001544_abnormal_cardiovascular_syste | 0.75171017 |
| 132 | MP0002089_abnormal_postnatal_growth/wei | 0.74137573 |
| 133 | MP0005058_abnormal_lysosome_morphology | 0.73732273 |
| 134 | MP0003953_abnormal_hormone_level | 0.72781226 |
| 135 | MP0001731_abnormal_postnatal_growth | 0.71552044 |
| 136 | MP0000681_abnormal_thyroid_gland | 0.71331952 |
| 137 | MP0003183_abnormal_peptide_metabolism | 0.71197722 |
| 138 | MP0005636_abnormal_mineral_homeostasis | 0.70741708 |
| 139 | MP0003045_fibrosis | 0.70490498 |
| 140 | MP0005334_abnormal_fat_pad | 0.69805576 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Myokymia (HP:0002411) | 5.18228139 |
| 2 | Focal motor seizures (HP:0011153) | 5.12552244 |
| 3 | Obstructive sleep apnea (HP:0002870) | 4.60044301 |
| 4 | Ventricular fibrillation (HP:0001663) | 4.08698869 |
| 5 | Visual hallucinations (HP:0002367) | 3.93192695 |
| 6 | Bundle branch block (HP:0011710) | 3.87781784 |
| 7 | Focal seizures (HP:0007359) | 3.80061938 |
| 8 | Exercise-induced myalgia (HP:0003738) | 3.56018808 |
| 9 | Diplopia (HP:0000651) | 3.49947481 |
| 10 | Abnormality of binocular vision (HP:0011514) | 3.49947481 |
| 11 | Action tremor (HP:0002345) | 3.47717536 |
| 12 | Sudden death (HP:0001699) | 3.33066470 |
| 13 | Gout (HP:0001997) | 3.03575731 |
| 14 | Truncus arteriosus (HP:0001660) | 3.01142660 |
| 15 | Dysdiadochokinesis (HP:0002075) | 2.97372159 |
| 16 | Annular pancreas (HP:0001734) | 2.96886259 |
| 17 | Generalized tonic-clonic seizures (HP:0002069) | 2.96521030 |
| 18 | Increased circulating renin level (HP:0000848) | 2.93353090 |
| 19 | Heart block (HP:0012722) | 2.84812803 |
| 20 | Absence seizures (HP:0002121) | 2.81976356 |
| 21 | Atrioventricular block (HP:0001678) | 2.80947416 |
| 22 | Progressive cerebellar ataxia (HP:0002073) | 2.77531037 |
| 23 | Syncope (HP:0001279) | 2.77250570 |
| 24 | Atonic seizures (HP:0010819) | 2.76538002 |
| 25 | Impaired social interactions (HP:0000735) | 2.73522268 |
| 26 | Abnormal social behavior (HP:0012433) | 2.73522268 |
| 27 | Hypercortisolism (HP:0001578) | 2.71097885 |
| 28 | Dysmetria (HP:0001310) | 2.66898483 |
| 29 | Exercise-induced muscle cramps (HP:0003710) | 2.66253378 |
| 30 | Poor eye contact (HP:0000817) | 2.65705090 |
| 31 | Broad-based gait (HP:0002136) | 2.65422544 |
| 32 | Anxiety (HP:0000739) | 2.65006660 |
| 33 | Calf muscle hypertrophy (HP:0008981) | 2.62560870 |
| 34 | Prolonged QT interval (HP:0001657) | 2.60270071 |
| 35 | Intention tremor (HP:0002080) | 2.59784892 |
| 36 | Ketoacidosis (HP:0001993) | 2.59613187 |
| 37 | Hyperglycinuria (HP:0003108) | 2.58664130 |
| 38 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.58514968 |
| 39 | Cerebral hypomyelination (HP:0006808) | 2.58084672 |
| 40 | Postural instability (HP:0002172) | 2.56571558 |
| 41 | Abnormal atrioventricular conduction (HP:0005150) | 2.56028887 |
| 42 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.55374051 |
| 43 | Growth hormone excess (HP:0000845) | 2.55129765 |
| 44 | Hyperactive renin-angiotensin system (HP:0000841) | 2.54393039 |
| 45 | Muscle fiber splitting (HP:0003555) | 2.53822313 |
| 46 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.52737454 |
| 47 | Depression (HP:0000716) | 2.51358857 |
| 48 | Ankle clonus (HP:0011448) | 2.50213455 |
| 49 | Atrial fibrillation (HP:0005110) | 2.49967766 |
| 50 | Difficulty running (HP:0009046) | 2.49029763 |
| 51 | Supranuclear gaze palsy (HP:0000605) | 2.48987219 |
| 52 | Dialeptic seizures (HP:0011146) | 2.48409230 |
| 53 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.47523849 |
| 54 | Hyperthyroidism (HP:0000836) | 2.46833385 |
| 55 | Neuronal loss in central nervous system (HP:0002529) | 2.46805641 |
| 56 | Dysmetric saccades (HP:0000641) | 2.46078359 |
| 57 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.44315217 |
| 58 | Abnormality of glycine metabolism (HP:0010895) | 2.44315217 |
| 59 | Ventricular arrhythmia (HP:0004308) | 2.43917217 |
| 60 | Cholecystitis (HP:0001082) | 2.43403885 |
| 61 | Abnormal gallbladder physiology (HP:0012438) | 2.43403885 |
| 62 | Urinary urgency (HP:0000012) | 2.43213411 |
| 63 | Metabolic alkalosis (HP:0200114) | 2.42073509 |
| 64 | Primary atrial arrhythmia (HP:0001692) | 2.39854403 |
| 65 | Myoglobinuria (HP:0002913) | 2.39374602 |
| 66 | Hyperglycinemia (HP:0002154) | 2.39335135 |
| 67 | Ketosis (HP:0001946) | 2.37764556 |
| 68 | Abnormality of saccadic eye movements (HP:0000570) | 2.35737175 |
| 69 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.34062474 |
| 70 | Adrenal overactivity (HP:0002717) | 2.33731214 |
| 71 | Hypokalemic alkalosis (HP:0001949) | 2.33084318 |
| 72 | Abnormal EKG (HP:0003115) | 2.32635661 |
| 73 | Hemiplegia (HP:0002301) | 2.32177092 |
| 74 | Hyperphosphatemia (HP:0002905) | 2.29893300 |
| 75 | Abnormal eating behavior (HP:0100738) | 2.28302099 |
| 76 | Hyporeflexia of lower limbs (HP:0002600) | 2.27766778 |
| 77 | Papilledema (HP:0001085) | 2.27599352 |
| 78 | Status epilepticus (HP:0002133) | 2.25853183 |
| 79 | Rigidity (HP:0002063) | 2.24010924 |
| 80 | Gaze-evoked nystagmus (HP:0000640) | 2.23737525 |
| 81 | Termporal pattern (HP:0011008) | 2.23650274 |
| 82 | Insidious onset (HP:0003587) | 2.23650274 |
| 83 | Torticollis (HP:0000473) | 2.22615664 |
| 84 | Genetic anticipation (HP:0003743) | 2.22076162 |
| 85 | Neurofibrillary tangles (HP:0002185) | 2.18944823 |
| 86 | Supraventricular tachycardia (HP:0004755) | 2.18716438 |
| 87 | Distal upper limb amyotrophy (HP:0007149) | 2.17324755 |
| 88 | Upper limb amyotrophy (HP:0009129) | 2.17324755 |
| 89 | Epileptic encephalopathy (HP:0200134) | 2.16930069 |
| 90 | Febrile seizures (HP:0002373) | 2.15446595 |
| 91 | Peripheral hypomyelination (HP:0007182) | 2.15237625 |
| 92 | Abnormality of the calf musculature (HP:0001430) | 2.15134553 |
| 93 | Progressive inability to walk (HP:0002505) | 2.12507326 |
| 94 | Supraventricular arrhythmia (HP:0005115) | 2.12409913 |
| 95 | Bradykinesia (HP:0002067) | 2.12229647 |
| 96 | Right ventricular cardiomyopathy (HP:0011663) | 2.11975027 |
| 97 | Ankyloglossia (HP:0010296) | 2.08236131 |
| 98 | Truncal ataxia (HP:0002078) | 2.07819127 |
| 99 | Cerebral inclusion bodies (HP:0100314) | 2.07166006 |
| 100 | Bowel incontinence (HP:0002607) | 2.05860055 |
| 101 | Sleep apnea (HP:0010535) | 2.03923075 |
| 102 | Urethral obstruction (HP:0000796) | 2.02858906 |
| 103 | Mutism (HP:0002300) | 2.02706364 |
| 104 | Male infertility (HP:0003251) | 2.01698175 |
| 105 | Lower limb asymmetry (HP:0100559) | 2.00403111 |
| 106 | Delusions (HP:0000746) | 1.98990880 |
| 107 | Spastic gait (HP:0002064) | 1.98962906 |
| 108 | Focal dystonia (HP:0004373) | 1.98042091 |
| 109 | Abnormality of the salivary glands (HP:0010286) | 1.97814326 |
| 110 | Hyperparathyroidism (HP:0000843) | 1.96722983 |
| 111 | Hyperaldosteronism (HP:0000859) | 1.96364542 |
| 112 | Hypoglycemic seizures (HP:0002173) | 1.95256944 |
| 113 | Pheochromocytoma (HP:0002666) | 1.93375560 |
| 114 | Hyperuricemia (HP:0002149) | 1.93004252 |
| 115 | Increased purine levels (HP:0004368) | 1.93004252 |
| 116 | Clonus (HP:0002169) | 1.92877558 |
| 117 | Scanning speech (HP:0002168) | 1.92020824 |
| 118 | Tetraplegia (HP:0002445) | 1.91494863 |
| 119 | Resting tremor (HP:0002322) | 1.89334157 |
| 120 | Abnormal large intestine physiology (HP:0012700) | 1.88659597 |
| 121 | Stereotypic behavior (HP:0000733) | 1.88628601 |
| 122 | Delayed CNS myelination (HP:0002188) | 1.88278656 |
| 123 | Slow saccadic eye movements (HP:0000514) | 1.87702253 |
| 124 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 1.87373666 |
| 125 | Hyperkalemia (HP:0002153) | 1.86617832 |
| 126 | Hyperventilation (HP:0002883) | 1.86584811 |
| 127 | Abnormality of the lower motor neuron (HP:0002366) | 1.85482780 |
| 128 | Hyperammonemia (HP:0001987) | 1.85113726 |
| 129 | Ileus (HP:0002595) | 1.84956535 |
| 130 | Abnormality of the corticospinal tract (HP:0002492) | 1.84264070 |
| 131 | Renal salt wasting (HP:0000127) | 1.84199805 |
| 132 | Foot dorsiflexor weakness (HP:0009027) | 1.83433344 |
| 133 | Abnormality of ocular smooth pursuit (HP:0000617) | 1.81181274 |
| 134 | Craniofacial dystonia (HP:0012179) | 1.81000288 |
| 135 | Abnormality of the foot musculature (HP:0001436) | 1.80962401 |
| 136 | Impaired vibratory sensation (HP:0002495) | 1.80830086 |
| 137 | Bronchomalacia (HP:0002780) | 1.80783939 |
| 138 | Choreoathetosis (HP:0001266) | 1.80291412 |
| 139 | Macroorchidism (HP:0000053) | 1.79853035 |
| 140 | Rapidly progressive (HP:0003678) | 1.79290256 |
| 141 | Myotonia (HP:0002486) | 1.78920320 |
| 142 | Ventricular tachycardia (HP:0004756) | 1.78840920 |
| 143 | Polar cataract (HP:0010696) | 1.78416246 |
| 144 | Seborrheic dermatitis (HP:0001051) | 1.78157510 |
| 145 | Abnormality of the Achilles tendon (HP:0005109) | 1.76438661 |
| 146 | Hemiparesis (HP:0001269) | 1.75903372 |
| 147 | Abnormality of glycolysis (HP:0004366) | 1.75544022 |
| 148 | Abnormality of chloride homeostasis (HP:0011422) | 1.74988763 |
| 149 | Hand muscle atrophy (HP:0009130) | 1.74934278 |
| 150 | Insomnia (HP:0100785) | 1.74074433 |
| 151 | Hypoglycemic coma (HP:0001325) | 1.74013921 |
| 152 | Increased variability in muscle fiber diameter (HP:0003557) | 1.73343505 |
| 153 | Abnormality of renin-angiotensin system (HP:0000847) | 1.72673458 |
| 154 | Muscle stiffness (HP:0003552) | 1.72097613 |
| 155 | Postural tremor (HP:0002174) | 1.71341785 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EPHA4 | 3.62582817 |
| 2 | NTRK3 | 3.30131701 |
| 3 | MAP3K9 | 3.10177564 |
| 4 | PRPF4B | 3.00010962 |
| 5 | CDK12 | 2.86112793 |
| 6 | PRKD3 | 2.54936286 |
| 7 | PAK6 | 2.37663500 |
| 8 | DAPK2 | 2.26100865 |
| 9 | MAP3K4 | 2.23154613 |
| 10 | KSR2 | 2.16590083 |
| 11 | WNK4 | 2.11823338 |
| 12 | MARK1 | 2.03481838 |
| 13 | PHKG1 | 2.03146407 |
| 14 | PHKG2 | 2.03146407 |
| 15 | STK38 | 2.02455468 |
| 16 | MAP2K4 | 1.94017159 |
| 17 | OXSR1 | 1.90979335 |
| 18 | STK39 | 1.84192011 |
| 19 | MINK1 | 1.79857046 |
| 20 | CAMKK1 | 1.76978953 |
| 21 | LMTK2 | 1.69396918 |
| 22 | PINK1 | 1.67681026 |
| 23 | TRIB3 | 1.65622433 |
| 24 | SMG1 | 1.58179673 |
| 25 | NTRK2 | 1.56506792 |
| 26 | NTRK1 | 1.51622081 |
| 27 | BRSK1 | 1.46649239 |
| 28 | TYRO3 | 1.42310253 |
| 29 | WNK1 | 1.40542434 |
| 30 | PAK3 | 1.39547032 |
| 31 | PDK3 | 1.38919076 |
| 32 | PDK4 | 1.38919076 |
| 33 | NEK1 | 1.37930020 |
| 34 | TAOK1 | 1.34566337 |
| 35 | DAPK1 | 1.34437509 |
| 36 | MAP3K2 | 1.32855433 |
| 37 | MAP2K7 | 1.27526532 |
| 38 | ERN1 | 1.26759098 |
| 39 | CDK5 | 1.26506831 |
| 40 | SIK1 | 1.24851865 |
| 41 | STK11 | 1.18711322 |
| 42 | MST4 | 1.17246934 |
| 43 | TNK2 | 1.15792443 |
| 44 | NEK6 | 1.13580791 |
| 45 | WNK3 | 1.11639911 |
| 46 | RIPK1 | 1.10785030 |
| 47 | DMPK | 1.10674597 |
| 48 | CAMK1G | 1.09650502 |
| 49 | PRKCH | 1.09167332 |
| 50 | FGFR3 | 1.08805771 |
| 51 | LATS2 | 1.07058599 |
| 52 | MST1R | 1.04910271 |
| 53 | FGFR4 | 1.02688215 |
| 54 | BMPR2 | 1.02155111 |
| 55 | ALK | 1.01872862 |
| 56 | EIF2AK1 | 1.01384274 |
| 57 | PDPK1 | 1.00720279 |
| 58 | SIK3 | 0.98614959 |
| 59 | EEF2K | 0.97209836 |
| 60 | CAMK1 | 0.96940097 |
| 61 | SGK223 | 0.96863422 |
| 62 | SGK494 | 0.96863422 |
| 63 | KSR1 | 0.96347369 |
| 64 | BMX | 0.95720920 |
| 65 | NME1 | 0.94807141 |
| 66 | PNCK | 0.94247324 |
| 67 | MAP3K7 | 0.92894460 |
| 68 | RET | 0.90670635 |
| 69 | PRKCG | 0.90539156 |
| 70 | MAPKAPK3 | 0.89178046 |
| 71 | HIPK2 | 0.88797366 |
| 72 | MAP3K13 | 0.88749533 |
| 73 | UHMK1 | 0.88511078 |
| 74 | BRD4 | 0.87803820 |
| 75 | PDK1 | 0.86381946 |
| 76 | CAMK2A | 0.86073049 |
| 77 | GRK5 | 0.82770569 |
| 78 | MAP2K6 | 0.79982513 |
| 79 | EPHA2 | 0.78146454 |
| 80 | SIK2 | 0.76285131 |
| 81 | SGK3 | 0.76204776 |
| 82 | CAMKK2 | 0.75931982 |
| 83 | SGK1 | 0.75839649 |
| 84 | OBSCN | 0.75348455 |
| 85 | CAMK2G | 0.74385404 |
| 86 | RIPK4 | 0.74288537 |
| 87 | TTN | 0.73721970 |
| 88 | FES | 0.73410194 |
| 89 | CDC42BPA | 0.72752239 |
| 90 | CAMK2D | 0.70177818 |
| 91 | TNIK | 0.69104090 |
| 92 | PDK2 | 0.68637277 |
| 93 | MAP3K1 | 0.66994358 |
| 94 | PRKG2 | 0.66679476 |
| 95 | CAMK2B | 0.66509728 |
| 96 | FGFR2 | 0.66427837 |
| 97 | PRKD1 | 0.65711946 |
| 98 | ARAF | 0.65701668 |
| 99 | PKN2 | 0.65210972 |
| 100 | CDK19 | 0.64057421 |
| 101 | TAOK2 | 0.61044540 |
| 102 | RPS6KA3 | 0.60593896 |
| 103 | BCKDK | 0.59083247 |
| 104 | TTK | 0.58809400 |
| 105 | CDK11A | 0.58479373 |
| 106 | CSNK1G2 | 0.58401007 |
| 107 | PDGFRA | 0.58358828 |
| 108 | SGK2 | 0.57718189 |
| 109 | STK24 | 0.57457375 |
| 110 | MARK2 | 0.56782177 |
| 111 | PTK2B | 0.56464814 |
| 112 | MAP2K1 | 0.54036048 |
| 113 | MTOR | 0.52941050 |
| 114 | MUSK | 0.52492310 |
| 115 | CAMK4 | 0.52156416 |
| 116 | PRKAA1 | 0.52052348 |
| 117 | CAMK1D | 0.51784292 |
| 118 | DYRK1A | 0.49753332 |
| 119 | FER | 0.49412106 |
| 120 | MAPK10 | 0.49166064 |
| 121 | PRKCZ | 0.48668426 |
| 122 | MAPK12 | 0.47724918 |
| 123 | CDK15 | 0.47512049 |
| 124 | CDK14 | 0.46937215 |
| 125 | ICK | 0.46623072 |
| 126 | PTK2 | 0.45755805 |
| 127 | TESK1 | 0.45612080 |
| 128 | PRKACG | 0.45599057 |
| 129 | CDK9 | 0.44404933 |
| 130 | PRKCE | 0.43945889 |
| 131 | SCYL2 | 0.43817437 |
| 132 | MAPKAPK5 | 0.43539831 |
| 133 | CSNK1E | 0.43275677 |
| 134 | PRKAA2 | 0.42992061 |
| 135 | MAP3K10 | 0.42830404 |
| 136 | GSK3B | 0.41270713 |
| 137 | CDK18 | 0.41235023 |
| 138 | RAF1 | 0.41136490 |
| 139 | MAPK11 | 0.39994169 |
| 140 | MAPK7 | 0.39734899 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.25266071 |
| 2 | Nicotine addiction_Homo sapiens_hsa05033 | 2.20116363 |
| 3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.12521062 |
| 4 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.99217800 |
| 5 | GABAergic synapse_Homo sapiens_hsa04727 | 1.98273293 |
| 6 | Olfactory transduction_Homo sapiens_hsa04740 | 1.89940048 |
| 7 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.85818013 |
| 8 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.82780237 |
| 9 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.81892474 |
| 10 | Circadian entrainment_Homo sapiens_hsa04713 | 1.81481424 |
| 11 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.78903222 |
| 12 | Histidine metabolism_Homo sapiens_hsa00340 | 1.76369144 |
| 13 | Long-term potentiation_Homo sapiens_hsa04720 | 1.75449783 |
| 14 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.72534295 |
| 15 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.71827934 |
| 16 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.71317530 |
| 17 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.68998368 |
| 18 | Morphine addiction_Homo sapiens_hsa05032 | 1.66149450 |
| 19 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.62416481 |
| 20 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.61837373 |
| 21 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.61713938 |
| 22 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.61069369 |
| 23 | Salivary secretion_Homo sapiens_hsa04970 | 1.60574178 |
| 24 | Insulin secretion_Homo sapiens_hsa04911 | 1.58945898 |
| 25 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.58897857 |
| 26 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.58050088 |
| 27 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.56326353 |
| 28 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.54107430 |
| 29 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.42257538 |
| 30 | Bile secretion_Homo sapiens_hsa04976 | 1.40923314 |
| 31 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.38023805 |
| 32 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.34472759 |
| 33 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.33797136 |
| 34 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.32573373 |
| 35 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.28804760 |
| 36 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.27430784 |
| 37 | Renin secretion_Homo sapiens_hsa04924 | 1.24937514 |
| 38 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.22904472 |
| 39 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.22081788 |
| 40 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.21966205 |
| 41 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.15768449 |
| 42 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.13895082 |
| 43 | Cocaine addiction_Homo sapiens_hsa05030 | 1.12907267 |
| 44 | Taste transduction_Homo sapiens_hsa04742 | 1.11714291 |
| 45 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.11595855 |
| 46 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.08171596 |
| 47 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.06809184 |
| 48 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.05355876 |
| 49 | Long-term depression_Homo sapiens_hsa04730 | 1.03764015 |
| 50 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.03204196 |
| 51 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.01403252 |
| 52 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.99775405 |
| 53 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.96585288 |
| 54 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.93586840 |
| 55 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.92764834 |
| 56 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.90016357 |
| 57 | Prion diseases_Homo sapiens_hsa05020 | 0.88079485 |
| 58 | Gap junction_Homo sapiens_hsa04540 | 0.85783675 |
| 59 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.85368575 |
| 60 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.84533411 |
| 61 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.83490062 |
| 62 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.82826896 |
| 63 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.81626282 |
| 64 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.80757378 |
| 65 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.79870132 |
| 66 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.79496665 |
| 67 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.79262251 |
| 68 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.79026179 |
| 69 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.78120812 |
| 70 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.78054718 |
| 71 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.77708629 |
| 72 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.76847414 |
| 73 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.75128391 |
| 74 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.75110592 |
| 75 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.74877453 |
| 76 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.74051085 |
| 77 | Carbon metabolism_Homo sapiens_hsa01200 | 0.72246693 |
| 78 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.71369397 |
| 79 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.71246190 |
| 80 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.67741486 |
| 81 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.67373362 |
| 82 | Melanogenesis_Homo sapiens_hsa04916 | 0.66444884 |
| 83 | Thyroid cancer_Homo sapiens_hsa05216 | 0.65942759 |
| 84 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.65383299 |
| 85 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.64864717 |
| 86 | Glioma_Homo sapiens_hsa05214 | 0.62002275 |
| 87 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.60375544 |
| 88 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.59933610 |
| 89 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.59617716 |
| 90 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.59367462 |
| 91 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.58615671 |
| 92 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.57877528 |
| 93 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.57729725 |
| 94 | Axon guidance_Homo sapiens_hsa04360 | 0.57020965 |
| 95 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.56296322 |
| 96 | Mineral absorption_Homo sapiens_hsa04978 | 0.55574611 |
| 97 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.54945122 |
| 98 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.53713940 |
| 99 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.52682223 |
| 100 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.52310562 |
| 101 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.51886399 |
| 102 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.51771819 |
| 103 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.51519049 |
| 104 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.50861033 |
| 105 | Insulin resistance_Homo sapiens_hsa04931 | 0.50804329 |
| 106 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.50182882 |
| 107 | Alzheimers disease_Homo sapiens_hsa05010 | 0.49626166 |
| 108 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.49549652 |
| 109 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.48982489 |
| 110 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.48161896 |
| 111 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.47822341 |
| 112 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.45840701 |
| 113 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.45002705 |
| 114 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.42302109 |
| 115 | Peroxisome_Homo sapiens_hsa04146 | 0.41500154 |
| 116 | Circadian rhythm_Homo sapiens_hsa04710 | 0.39890821 |
| 117 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.39707974 |
| 118 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.39492535 |
| 119 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.39216204 |
| 120 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.39081946 |
| 121 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.39010446 |
| 122 | Parkinsons disease_Homo sapiens_hsa05012 | 0.37939297 |
| 123 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.37122737 |
| 124 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.36920619 |
| 125 | Lysine degradation_Homo sapiens_hsa00310 | 0.36667668 |

